Williams, A. D., McGreevy, C. M., Tchou, J. C., & De La Cruz, L. M. (2020). Utility of Oncotype DX in Male Breast Cancer Patients and Impact on Chemotherapy Administration. Annals of Surgical Oncology, 27(10), 3605-3611. https://doi.org/10.1245/s10434-020-08473-y
Chicago Style (17th ed.) CitationWilliams, Austin D., Christopher M. McGreevy, Julia C. Tchou, and Lucy M. De La Cruz. "Utility of Oncotype DX in Male Breast Cancer Patients and Impact on Chemotherapy Administration." Annals of Surgical Oncology 27, no. 10 (2020): 3605-3611. https://doi.org/10.1245/s10434-020-08473-y.
MLA (9th ed.) CitationWilliams, Austin D., et al. "Utility of Oncotype DX in Male Breast Cancer Patients and Impact on Chemotherapy Administration." Annals of Surgical Oncology, vol. 27, no. 10, 2020, pp. 3605-3611, https://doi.org/10.1245/s10434-020-08473-y.